Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 NOK | +5.10% | +1.73% | -40.65% |
Sales 2023 | 354K 32.43K | Sales 2024 * | - | Capitalization | 614M 56.22M |
---|---|---|---|---|---|
Net income 2023 | -190M -17.41M | Net income 2024 * | -195M -17.87M | EV / Sales 2023 | 1,670 x |
Net cash position 2023 | 156M 14.33M | Net Debt 2024 * | 70.86M 6.49M | EV / Sales 2024 * | - |
P/E ratio 2023 |
-2.14
x | P/E ratio 2024 * |
-2.17
x | Employees | 25 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 46.59% |
Latest transcript on BerGenBio ASA
1 day | +0.25% | ||
1 week | -2.96% | ||
Current month | -18.87% | ||
1 month | -8.49% | ||
3 months | -47.09% | ||
6 months | -7.95% | ||
Current year | -43.38% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Olin
CEO | Chief Executive Officer | 55 | 21-09-07 |
Rune Skeie
DFI | Director of Finance/CFO | 51 | 18-03-04 |
Nigel McCracken
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sally Bennett
BRD | Director/Board Member | 52 | 20-12-08 |
Sveinung Hole
BRD | Director/Board Member | 57 | 10-08-31 |
Chairman | 63 | 22-01-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.165 | +5.10% | 14 653 846 |
24-04-23 | 0.157 | -0.25% | 16,016,930 |
24-04-22 | 0.1574 | -3.67% | 9,529,377 |
24-04-19 | 0.1634 | +0.99% | 12,252,360 |
24-04-18 | 0.1618 | -0.25% | 19,036,300 |
Real-time Oslo Bors, April 24, 2024 at 03:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.38% | 56.14M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.39% | 22.19B | |
-16.16% | 21.33B | |
-7.42% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- BGBIO Stock